Axios’ Erin Brodwin published a new investigation which discovered healthcare automation startup Olive is exaggerating its capabilities and only uses “rough estimations” to gauge its cost savings.
Olive exaggerates cost savings; Happify Health reports DTx curbs anxiety in psoriasis patients; and other digital health briefs
